The Synergistic Pharmacologic Intervention for Prevention of ROP (SPIPROP STUDY)

Trial Profile

The Synergistic Pharmacologic Intervention for Prevention of ROP (SPIPROP STUDY)

Recruiting
Phase of Trial: Phase II

Latest Information Update: 06 Oct 2017

At a glance

  • Drugs Caffeine citrate (Primary) ; Ibuprofen (Primary) ; Ketorolac (Primary)
  • Indications Retinopathy of prematurity
  • Focus Therapeutic Use
  • Acronyms SPIPROP study
  • Most Recent Events

    • 03 Oct 2017 Planned End Date changed from 30 Jun 2017 to 30 Jun 2019.
    • 03 Oct 2017 Planned primary completion date changed from 30 Jun 2017 to 30 Jun 2018.
    • 10 Apr 2017 Planned End Date changed from 1 Dec 2016 to 30 Jun 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top